Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.83 Analyst target: $14.15 Upside: 107.17%
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.